First Child to Receive Revolutionary CAR T Therapy Celebrates 10 Years Cancer Free
May 11, 2022
Emily Whitehead, now 17, received life-saving treatment at CHOP, transforming the field of cancer immunotherapy.
Cancer Center News
Your child will be cared for by one of the most accomplished teams of childhood cancer experts in the world. We provide medical care, emotional counseling and much more. We make sure your child, you and every family member get the highest level of support.
Existing patients or family members
New patients, referrals and second opinions
Emily Whitehead, First Pediatric Patient to Receive CAR T-Cell Therapy, Celebrates Cure 10 Years Later
May 11, 2022
Whitehead received life-saving treatment at CHOP, under the care of Dr. Stephan Grupp, transforming the field of cancer immunotherapy.
CHOP Oncologists Recognized at 2022 ASPHO Conference
May 5, 2022
Drs. Yael Mossé and Sogol Mostoufi-Moab were recognized at the 2022 ASPHO Conference for their outstanding contributions in the field of pediatric oncology.
AYA Cancer Awareness Month: Behavioral Scientist Spotlight
Apr 5, 2022
Adolescents and young adults (AYA) with cancer have unique emotional and social needs. Meet a clinical psychologist who is focused on strategies to help AYAs manage their own health and medications.
AYA Cancer Awareness Month: Patient Spotlights
Apr 20, 2023
CHOP’s Cancer Center provides special services for adolescent and young adult (AYA) patients. Meet some of those patients and learn about their journeys.
CHOP Researchers Uncover Unique Mechanism for Cancer Therapy Resistance
Apr 1, 2022
CHOP researchers have found that multidrug resistant tumors have reduced connections between mitochondria and endoplasmic reticulum, causing signaling dysfunction.
Children’s Hospital of Philadelphia Establishes the Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy
Mar 28, 2022
A transformative gift from local philanthropists Steve and Susan Kelly launches first-of-its-kind hub for pediatric cancer immunotherapy.
CHOP Brings Together Experts to Discuss Precision Medicine in Pediatric Cancer Care
Mar 18, 2022
More than 250 experts gathered in Philadelphia and virtually to discuss the latest scientific advancements and breakthroughs in pediatric precision medicine oncology.
CHOP Researchers Refine Experimental Prodrug Treatment of High-Risk Neuroblastoma
Mar 14, 2022
CHOP researchers have shown that linking a tumor-killing prodrug to a macromolecular carrier of the Poloxamer family improves retention of the drug in treatment-resistant neuroblastoma tumors.
CHOP-Led Study Finds Bortezomib Improves Survival in Children with Newly Diagnosed T-Cell Lymphoblastic Lymphoma
Mar 10, 2022
In a COG trial, CHOP researchers found adding bortezomib to chemotherapy significantly improved overall survival in children and young adults with newly diagnosed T-cell lymphoblastic lymphoma (T-LL).